Based on recent data, VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) shows an Average True Range (ATR) of 0.62 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 19.31K, indicating liquidity. These fundamental metrics provide insight into CDC's underlying financial health and market activity.
| ATR | 0.62 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 19.31K |
| Avg Vol (10 Days) | 24.19K |
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) technical indicators as of April 4, 2026: the SMA 20 is 1.61%, SMA 50 at 6.06%, and SMA 200 at 11.03%. The RSI 14 value is 73.3, suggesting its current momentum. These technical analysis signals help assess CDC's price trends and potential future movements.
| SMA 20 | 1.61% |
| SMA 50 | 6.06% |
| SMA 200 | 11.03% |
| RSI 14 | 73.3 |
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) stock performance overview as of April 4, 2026: The 52-week high is $74.07 (currently -0.52% below), and the 52-week low is $57.37 (currently 28% above). Over the past year, CDC's performance is N/A, compared to the S&P 500's 16.47% change.
| 52-Week High | 74.07 |
| 52-Week High Chg | -0.52% |
| 52-Week Low | 57.37 |
| 52-Week Low Chg | +28.00% |
| S&P 500 52-Week Chg | 16.47% |
According to market data, VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) stock's recent performance metrics show that over the last month, CDC is N/A, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize CDC's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 71.47 | 74.07 | 74.07 | 74.07 | 74.07 | 74.07 |
| Low | 70.45 | 69.42 | 65.52 | 64.3 | 57.37 | 65.52 |
| Performance | - | - | - | - | - | - |
According to current financial data, CDC stock's P/E (TTM) ratio is N/A, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -6.59. Key valuation ratios for CDC, including P/S (N/A), P/B (N/A), and P/FCF (N/A), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CDC | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | N/A | -6.59 | 4.99 | 32.59 |
| P/S (TTM) | N/A | 2.46 | 374.78 | 5.98 |
| P/B (TTM) | N/A | N/A | 1.32 | 4.73 |
| P/FCF (TTM) | N/A | N/A | 841.79 | 32.89 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep